Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $124.0900 (0.78%) ($121.7400 - $124.9700) on Thu. Jul. 19, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.77% (three month average) | RSI | 81 | Latest Price | $124.0900(0.78%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR advances 3.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) IBB(44%) XLV(44%) XBI(43%) VFMO(40%) VT(40%) | Factors Impacting UTHR price | UTHR will decline at least -0.885% in a week (0% probabilities). VXX(-14%) VIXM(-13%) TLT(-13%) UUP(-10%) ONLN(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.885% (StdDev 1.77%) | Hourly BBV | 0 () | Intraday Trend | 0.6% | | | |
|
5 Day Moving Average | $123.62(0.38%) | 10 Day Moving Average | $123.05(0.85%) | 20 Day Moving Average | $118.72(4.52%) | To recent high | -0.5% | To recent low | 22.7% | Market Cap | $5.504b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |